Quantum-Si Partners with NVIDIA to Advance AI-Powered Protein Sequencing Technology

Quantum-Si and NVIDIA Join Forces to Revolutionize Proteomics

Quantum-Si Incorporated (NASDAQ: QSI) has announced a groundbreaking collaboration with NVIDIA Corporation (NASDAQ: NVDA) to develop Proteus, a cutting-edge proteomics platform 1

1

. This partnership aims to leverage NVIDIA's AI and accelerated computing capabilities to advance Quantum-Si's core technologies in amino acid binders and aminopeptidases, potentially transforming the landscape of protein sequencing and analysis 2

2

.

Enhancing Data Processing for Single-Molecule Proteomics

The collaboration's primary focus is to significantly boost data processing speeds to manage the increased data volume generated by Proteus. By combining NVIDIA's accelerated computing with Quantum-Si's advanced single-molecule protein sequencing and detection technologies, the partnership aims to develop a robust data processing system capable of keeping pace with rapidly evolving technological advancements 2

2

.

Dr. John Vieceli, Chief Product Officer of Quantum-Si, expressed enthusiasm about the collaboration, stating, "We are thrilled to collaborate with NVIDIA to make single-molecule proteomics more accessible to researchers. We have been leveraging AI protein structure prediction tools with NVIDIA BioNeMo, both in the cloud and on-premises to design new and improved biomolecules" 1

1

.

Expanding Partnerships and Distribution

In addition to the NVIDIA collaboration, Quantum-Si has announced several strategic partnerships to support the development and commercialization of Proteus:

1. SkyWater Technology: Quantum-Si is expanding its relationship with SkyWater to develop the consumable for Proteus, enabling simultaneous large-factor protein sequencing 1

   1

   .

2. Planet Innovation: This partnership focuses on the development and manufacture of Proteus. Planet Innovation is currently the contract manufacturer for Quantum-Si's Platinum Pro instrument, set to debut in the first half of 2025 1

   1

   .

3. Avantor Inc (NYSE: AVTR): A distribution agreement has been established, allowing Avantor to distribute Quantum-Si's Next-Generation Protein Sequencing (NGPS) portfolio to researchers across all market segments in the U.S. and Canada 1

   1

   .

Market Impact and Future Prospects

The announcement of these collaborations, particularly with NVIDIA, has had a significant impact on Quantum-Si's stock performance. On Wednesday, QSI stock traded over 100% higher, reaching $1.39 during the premarket session 1

1

. This surge in stock price reflects investor optimism about the potential of Quantum-Si's technology and its strategic partnerships.

The collaboration between Quantum-Si and NVIDIA is expected to generate single-molecule protein insights that could deepen our understanding of the proteome and lead to innovative solutions in research, drug discovery, and healthcare AI 2

2

. As the field of proteomics continues to evolve, this partnership may play a crucial role in advancing scientific knowledge and developing new therapeutic approaches.